Post by Waters Corporation

Today is an exciting and transformational day for our Company! Waters Corporation announced an agreement to combine with BD's Biosciences & Diagnostic Solutions business, creating a life science and diagnostics leader focused on regulated, high-volume testing. This unique opportunity will unite two industry leaders with a legacy of pioneering science and a shared culture of innovation. By bringing together Waters’ leadership in downstream analytical workflows with BD’s strength in cellular analysis and molecular diagnostics, we are creating a company well-positioned to deliver long-term benefits to our customers and shareholders. This combination places us at the center of some of the most resilient and durable end-markets in science and healthcare. We look forward to welcoming our new colleagues at close, which we expect around the end of the first quarter of calendar year 2026. Visit the newsroom to learn more: https://lnkd.in/d5-BMxpN

Video Content